OTCQB:BIXT - Post by User
Post by
amritadaniqueon Oct 11, 2023 7:39am
75 Views
Post# 35678216
"$BIXT: Revolutionising Biotech for Healthier Lives"
"$BIXT: Revolutionising Biotech for Healthier Lives"Bioxytran, Inc. ($BIXT) is a clinical-stage biotechnology company developing novel therapies targeting the treatment of significant unmet medical needs in virology, degenerative disease, and hypoxia. The leading drug candidate, Prolectin-M, is a new class of antiviral drug designed to antagonize galectins implicated in inflammatory, fibrotic, and malignant diseases. With a market cap of over $25.4 million, 144,355,355 outstanding shares, and a strong 30-day average volume of 207,046, Bioxytran is poised to make a significant impact in the biotech industry.